| scholarly article | Q13442814 |
| P50 | author | Eleanor Riley | Q27925452 |
| Teun Bousema | Q44168464 | ||
| Thomas S Churcher | Q54802124 | ||
| Chris J Drakeley | Q56774786 | ||
| P2093 | author name string | Colin J Sutherland | |
| Geoffrey A T Targett | |||
| Louis C Gouagna | |||
| Bert Mulder | |||
| P2860 | cites work | The limits and intensity of Plasmodium falciparum transmission: implications for malaria control and elimination worldwide | Q21563408 |
| Impact of artemisinin-based combination therapy and insecticide-treated nets on malaria burden in Zanzibar | Q22061782 | ||
| Reduction of malaria transmission to Anopheles mosquitoes with a six-dose regimen of co-artemether | Q24792020 | ||
| Effect of artemether-lumefantrine policy and improved vector control on malaria burden in KwaZulu-Natal, South Africa | Q24810617 | ||
| Malaria: progress, perils, and prospects for eradication | Q27485634 | ||
| Impact of the large-scale deployment of artemether/lumefantrine on the malaria disease burden in Africa: case studies of South Africa, Zambia and Ethiopia | Q27497242 | ||
| Increased density but not prevalence of gametocytes following drug treatment of Plasmodium falciparum | Q41946558 | ||
| Seasonal patterns of Plasmodium falciparum gametocyte prevalence and density in a rural population of Burkina Faso | Q43932462 | ||
| A longitudinal study of immune responses to Plasmodium falciparum sexual stage antigens in Tanzanian adults | Q43945792 | ||
| Reduction and enhancement of Plasmodium falciparum transmission by endemic human sera | Q43946800 | ||
| Transmission-reducing immunity is inversely related to age in Plasmodium falciparum gametocyte carriers | Q43946977 | ||
| Estimates of the infectious reservoir of Plasmodium falciparum malaria in The Gambia and in Tanzania | Q43951299 | ||
| Measurement of malarial infectivity of human populations to mosquitoes in the Madang area, Papua New Guinea | Q44065622 | ||
| Association between anti-Pfs48/45 reactivity and P. falciparum transmission-blocking activity in sera from Cameroon | Q44137386 | ||
| Gametocyte infectivity by direct mosquito feeds in an area of seasonal malaria transmission: implications for Bancoumana, Mali as a transmission-blocking vaccine site | Q44139692 | ||
| Efficacy model for mosquito stage transmission blocking vaccines for malaria | Q44140071 | ||
| Plasmodium falciparum: infectivity of cultured, synchronized gametocytes to mosquitoes | Q44140371 | ||
| Plasmodium falciparum: membrane feeding assays and competition ELISAs for the measurement of transmission reduction in sera from Cameroon | Q44140956 | ||
| The reservoir of Plasmodium falciparum malaria in a holoendemic area of western Kenya | Q44141767 | ||
| Transmission-blocking immunity to Plasmodium falciparum in malaria-immune individuals is associated with antibodies to the gamete surface protein Pfs230. | Q44142097 | ||
| Transmission blocking immunity to human Plasmodium vivax malaria in an endemic population in Kataragama, Sri Lanka | Q44142213 | ||
| Comparison of artificial membrane feeding with direct skin feeding to estimate infectiousness of Plasmodium falciparum gametocyte carriers to mosquitoes | Q44142810 | ||
| Properties of epitopes of pfs 48/45, a target of transmission blocking monoclonal antibodies, on gametes of different isolates of plasmodium falciparum | Q44143594 | ||
| Monoclonal and polyclonal antibodies both block and enhance transmission of human Plasmodium vivax malaria | Q44149896 | ||
| Antibodies to plasmodium falciparum gamete surface antigens in papua new guinea sera | Q44150700 | ||
| Estimation of malaria transmission from humans to mosquitoes in two neighbouring villages in south Cameroon: evaluation and comparison of several indices | Q44151632 | ||
| Infectivity to mosquitoes of Plasmodium falciparum as related to gametocyte density and duration of infection. | Q44152909 | ||
| Stage-specific effects of host plasma factors on the early sporogony of autologous Plasmodium falciparum isolates within Anopheles gambiae | Q44161813 | ||
| Studies on the use of a membrane feeding technique for infecting Anopheles gambiae with Plasmodium falciparum | Q44166943 | ||
| Sexual-stage antibody responses to P. falciparum in endemic populations | Q44167654 | ||
| Moderate effect of artemisinin-based combination therapy on transmission of Plasmodium falciparum | Q44167789 | ||
| Plasmodium falciparum malaria transmission-blocking immunity under conditions of low endemicity as in Sri Lanka | Q44170313 | ||
| Submicroscopic Plasmodium falciparum gametocyte densities frequently result in mosquito infection. | Q44171862 | ||
| Effects of anticoagulants on Plasmodium vivax oocyst development in Anopheles albimanus mosquitoes | Q44173151 | ||
| (Sub)microscopic Plasmodium falciparum gametocytaemia in Kenyan children after treatment with sulphadoxine-pyrimethamine monotherapy or in combination with artesunate | Q46962726 | ||
| Why so few transmission stages? Reproductive restraint by malaria parasites | Q47989667 | ||
| Proteins of the malaria parasite sexual stages: expression, function and potential for transmission blocking strategies | Q27973462 | ||
| Chloroquine/sulphadoxine-pyrimethamine for gambian children with malaria: transmission to mosquitoes of multidrug-resistant Plasmodium falciparum | Q28469025 | ||
| Primaquine clears submicroscopic Plasmodium falciparum gametocytes that persist after treatment with sulphadoxine-pyrimethamine and artesunate | Q28469316 | ||
| The dynamics of naturally acquired immune responses to Plasmodium falciparum sexual stage antigens Pfs230 & Pfs48/45 in a low endemic area in Tanzania | Q28744581 | ||
| Evaluation of the standard membrane feeding assay (SMFA) for the determination of malaria transmission-reducing activity using empirical data. | Q30982324 | ||
| Infectivity of asymptomatic Plasmodium-infected human populations to Anopheles dirus mosquitoes in western Thailand | Q33200838 | ||
| Rapid onset of transmission-reducing antibodies in javanese migrants exposed to malaria in papua, indonesia | Q33235842 | ||
| Plasmodium falciparum antigens on the surface of the gametocyte-infected erythrocyte | Q33338492 | ||
| Substantial contribution of submicroscopical Plasmodium falciparum gametocyte carriage to the infectious reservoir in an area of seasonal transmission | Q33520254 | ||
| Evidence for specific suppression of gametocytemia by Plasmodium falciparum in residents of hyperendemic Irian Jaya | Q33528315 | ||
| Malaria transmission-blocking vaccines--how can their development be supported? | Q33853275 | ||
| Immunity to asexual blood stage malaria and vaccine approaches | Q34842236 | ||
| Mosquito midguts and malaria: cell biology, compartmentalization and immunology. | Q36423176 | ||
| The epidemiology of Plasmodium falciparum gametocytes: weapons of mass dispersion | Q36538665 | ||
| Antibody responses to Plasmodium falciparum and P. vivax sporozoites in areas with stable and unstable malaria | Q36668494 | ||
| Malaria transmission-blocking vaccines: the bonus of effective malaria control | Q36785468 | ||
| Treatment uptake by individuals infected with Plasmodium falciparum in rural Gambia, West Africa. | Q36937696 | ||
| A randomized trial to monitor the efficacy and effectiveness by QT-NASBA of artemether-lumefantrine versus dihydroartemisinin-piperaquine for treatment and transmission control of uncomplicated Plasmodium falciparum malaria in western Kenya | Q37010425 | ||
| The role of anti-malarial drugs in eliminating malaria | Q37018629 | ||
| Malaria vaccines and their potential role in the elimination of malaria | Q37018637 | ||
| Changes in malaria indices between 1999 and 2007 in The Gambia: a retrospective analysis | Q37023452 | ||
| Plasmodium falciparum gametocyte dynamics in areas of different malaria endemicity | Q37082655 | ||
| Marked increase in child survival after four years of intensive malaria control | Q37108863 | ||
| Control to elimination: implications for malaria research | Q37257297 | ||
| Do we still need a malaria vaccine? | Q37582436 | ||
| Parasite infectivity and immunity to Plasmodium falciparum gametocytes in Gambian children | Q38977779 | ||
| The primary antibody response of malaria patients to Plasmodium falciparum sexual stage antigens which are potential transmission blocking vaccine candidates | Q39324954 | ||
| Artesunate reduces but does not prevent posttreatment transmission of Plasmodium falciparum to Anopheles gambiae. | Q39511728 | ||
| Plasmodium falciparum transmission blocking immunity under conditions of low and high endemicity in Cameroon | Q39688611 | ||
| Transmission of Plasmodium falciparum in urban Yaoundé, Cameroon, is seasonal and age-dependent | Q39690044 | ||
| Transmission blockade of Plasmodium falciparum malaria by anti-Pfs230-specific antibodies is isotype dependent | Q39821154 | ||
| Health seeking behavior after fever onset in a malaria-endemic area of Malawi | Q39911136 | ||
| Regulation of infectivity of Plasmodium to the mosquito vector | Q41029519 | ||
| Addition of artesunate to chloroquine for treatment of Plasmodium falciparum malaria in Gambian children causes a significant but short-lived reduction in infectiousness for mosquitoes | Q41914713 | ||
| Experimental infections of Anopheles gambiae with Plasmodium falciparum of naturally infected gametocyte carriers in Cameroon: factors influencing the infectivity to mosquitoes | Q41936628 | ||
| Infectivity of cultured Plasmodium falciparum gametocytes to mosquitoes | Q41946006 | ||
| P433 | issue | 3-4 | |
| P921 | main subject | Plasmodium falciparum | Q311383 |
| P304 | page(s) | 293-300 | |
| P577 | publication date | 2010-10-23 | |
| P1433 | published in | International Journal for Parasitology | Q6051284 |
| P1476 | title | Human immune responses that reduce the transmission of Plasmodium falciparum in African populations | |
| P478 | volume | 41 |
| Q92965786 | Antibodies against Plasmodium falciparum malaria at the molecular level |
| Q36433138 | Characterization of the infectious reservoir of malaria with an agent-based model calibrated to age-stratified parasite densities and infectiousness |
| Q40105545 | Concentration of Plasmodium falciparum gametocytes in whole blood samples by magnetic cell sorting enhances parasite infection rates in mosquito feeding assays |
| Q38917744 | Determinants of Malaria Transmission at the Population Level |
| Q44144794 | Development of a transmission-blocking malaria vaccine: progress, challenges, and the path forward |
| Q40089655 | Do the venous blood samples replicate malaria parasite densities found in capillary blood? A field study performed in naturally-infected asymptomatic children in Cameroon. |
| Q27007534 | Ensuring transmission through dynamic host environments: host-pathogen interactions in Plasmodium sexual development |
| Q34177472 | Epidemiology and infectivity of Plasmodium falciparum and Plasmodium vivax gametocytes in relation to malaria control and elimination |
| Q36187804 | Estimating malaria transmission from humans to mosquitoes in a noisy landscape |
| Q35022983 | Human-to-mosquito transmission efficiency increases as malaria is controlled |
| Q63493282 | Immune Responses to the Sexual Stages of Parasites |
| Q92001627 | Immunity against sexual stage Plasmodium falciparum and Plasmodium vivax parasites |
| Q38628567 | Life-span of in vitro differentiated Plasmodium falciparum gametocytes |
| Q36795388 | Malaria transmission blocking immunity and sexual stage vaccines for interrupting malaria transmission in Latin America. |
| Q28486274 | Malaria's missing number: calculating the human component of R0 by a within-host mechanistic model of Plasmodium falciparum infection and transmission |
| Q54217209 | Modeling the impact of Plasmodium falciparum sexual stage immunity on the composition and dynamics of the human infectious reservoir for malaria in natural settings. |
| Q28482471 | Mosquito feeding assays to determine the infectiousness of naturally infected Plasmodium falciparum gametocyte carriers |
| Q35598030 | Naturally acquired immune responses to Plasmodium falciparum sexual stage antigens Pfs48/45 and Pfs230 in an area of seasonal transmission |
| Q38689928 | Naturally acquired immunity to sexual stage P. falciparum parasites. |
| Q36063764 | Optimization of a Membrane Feeding Assay for Plasmodium vivax Infection in Anopheles albimanus |
| Q54255226 | Plasmodium Gametocytes in Field Studies: Do We Measure Commitment to Transmission or Detectability? |
| Q36138015 | Plasmodium falciparum Gametocyte-Specific Antibody Profiling Reveals Boosting through Natural Infection and Identifies Potential Markers of Gametocyte Exposure |
| Q38818196 | Recognition of Plasmodium falciparum mature gametocyte-infected erythrocytes by antibodies of semi-immune adults and malaria-exposed children from Gabon |
| Q28821671 | Similar trends of susceptibility in Anopheles arabiensis and Anopheles pharoensis to Plasmodium vivax infection in Ethiopia |
| Q28082362 | Targeting Human Transmission Biology for Malaria Elimination |
| Q34142771 | The Plasmodium bottleneck: malaria parasite losses in the mosquito vector |
| Q49732059 | Unravelling the immune signature of Plasmodium falciparum transmission-reducing immunity |
| Q54258053 | What goes around comes around: modeling malaria transmission from humans back to mosquitos. |
Search more.